Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Baxter
Colorcon
McKinsey
Harvard Business School
Moodys
Mallinckrodt

Last Updated: November 20, 2019

DrugPatentWatch Database Preview

Meningococcal group b vaccine - Biologic Drug Details

See Plans and Pricing

« Back to Dashboard

Summary for meningococcal group b vaccine
Tradenames:1
Patents:1
Applicants:1
BLAs:1
Suppliers: see list1
Recent Clinical Trials: See clinical trials for meningococcal group b vaccine
Recent Clinical Trials for meningococcal group b vaccine

Identify potential brand extensions & biosimilar entrants

SponsorPhase
LEO PharmaPhase 2
Medecins Sans Frontieres, NetherlandsPhase 4
EpicentrePhase 4

See all meningococcal group b vaccine clinical trials

Patent Text Search: US Patents for meningococcal group b vaccine

These patents were identified by searching patent claims

Supplementary Protection Certificates for meningococcal group b vaccine

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
15/072 Ireland   Start Trial PRODUCT NAME: MENINGOCOCCAL GROUP C OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM 197 PROTEIN, MENINGOCOCCAL GROUP W135 OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM 197 PROTEIN AND MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM 197 PROTEIN; REGISTRATION NO/DATE: EU/1/10/614/001 20100315
C/GB12/055 United Kingdom   Start Trial PRODUCT NAME: A) MENINGOCOCCAL GROUP A OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPTHERIAE CRM197 PROTEIN; B)MENINGOCOCCAL GROUP C OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPTHERIAE CRM197 PROTEIN; C)MENINGOCOCCAL GROUP W-135 OLIGOSACCHARIDE CONJUGATED TO CO; REGISTERED: UK EU/1/10/614/001 20100317
12/044 Ireland   Start Trial PRODUCT NAME: MENVEO: MENINGOCOCCAL GROUP A OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN, MENINGOCOCCAL GROUP C OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN, MENINGOCOCCAL GROUP W-135 OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN, MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN; REGISTRATION NO/DATE: EU/1/10/614/001 20100315; PAEDIATRIC INVESTIGATION PLAN: P/93/2011
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
McKesson
McKinsey
Harvard Business School
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.